[1] Mayadev JS, Ke G, Mahantshetty U, et al. Global challenges of radiotherapy for the treatment of locally advanced cervical cancer[J]. Int J Gynecol Cancer, 2022,32(3):436-445. DOI: 10.1136/ijgc-2021-003001.
[2] 陈晓琳,杨贞. HR-HPV载量与宫颈上皮内病变及宫颈癌相关性的研究进展[J]. 国际医药卫生导报,2024,30(6):932-935. DOI:10.3760/cma.j.issn.1007-1245.2024. 06.010.
[3] Feng CH, Mell LK, Sharabi AB, et al. Immunotherapy with radiotherapy and chemoradiotherapy for cervical cancer[J]. Semin Radiat Oncol, 2020,30(4):273-280. DOI: 10.1016/j.semradonc.2020.05.003.
[4] Tu S, Zhang H, Yang X, et al. Screening of cervical cancer-related hub genes based on comprehensive bioinformatics analysis[J]. Cancer Biomark, 2021,32(3):303-315. DOI: 10.3233/CBM-203262.
[5] Chen Q, Zhou L, Ma D, et al. LncRNA GAS6-AS1 facilitates tumorigenesis and metastasis of colorectal cancer by regulating TRIM14 through miR-370-3p/miR-1296-5p and FUS[J]. J Transl Med, 2022,20(1):356. DOI: 10.1186/s12967-022-03550-0.
[6] Zhang P, Dong Q, Zhu H, et al. Long non-coding antisense RNA GAS6-AS1 supports gastric cancer progression via increasing GAS6 expression[J]. Gene, 2019,696:1-9. DOI: 10.1016/j.gene.2018.12.079.
[7] Li SJ, Wu YX, Liang YH, et al. LncRNA HANR aggravates the progression of non-small cell lung cancer via mediating miRNA-140-5p[J]. Eur Rev Med Pharmacol Sci, 2020,24(2):704-711. DOI: 10.26355/eurrev_202001_20049.
[8] Zhou Q, Xie Y, Wang L, et al. LncRNA EWSAT1 upregulates CPEB4 via miR-330-5p to promote cervical cancer development[J]. Mol Cell Biochem, 2020,471(1-2):177-188. DOI: 10.1007/s11010-020-03778-8.
[9] Hou S, Zhang X, Yang J. Long non-coding RNA ABHD11-AS1 facilitates the progression of cervical cancer by competitively binding to miR-330-5p and upregulating MARK2[J]. Exp Cell Res, 2022,410(1):112929. DOI: 10.1016/j.yexcr.2021.112929.
[10] 庞敏,邓芳,李珊珊.环状RNA Circ_0000291/miR-326/PTBP1轴影响肝细胞癌进展[J].中国免疫学杂志,2024,40(6):1210-1216. DOI:10.3969/j.issn.1000- 484X. 2024.06.016.
[11] Cen Y, Zhu T, Zhang Y, et al. hsa_circ_0005358 suppresses cervical cancer metastasis by interacting with PTBP1 protein to destabilize CDCP1 mRNA[J]. Mol Ther Nucleic Acids,2021,27:227-240. DOI: 10.1016/j.omtn. 2021.11.020.
[12] Sadoughi F, Asemi Z, Yousefi B, et al. Cervical cancer and novel therapeutic and diagnostic approaches using chitosan as a carrier: a review[J]. Curr Pharm Des,2022,28(24):1966-1974. DOI: 10.2174/1381612828666220512101538.
[13] Dzinamarira T, Moyo E, Dzobo M, et al. Cervical cancer in sub-Saharan Africa: an urgent call for improving accessibility and use of preventive services[J]. Int J Gynecol Cancer,2023,33(4):592-597. DOI: 10.1136/ijgc-2022-003957.
[14] Alfaro K, Maza M, Cremer M, et al. Removing global barriers to cervical cancer prevention and moving towards elimination[J]. Nat Rev Cancer, 2021,21(10):607-608. DOI: 10.1038/s41568-021-00396-4.
[15] Li RB, Yang XH, Zhang JD, et al. GAS6-AS1, a long noncoding RNA, functions as a key candidate gene in atrial fibrillation related stroke determined by ceRNA network analysis and WGCNA[J]. BMC Med Genomics, 2023,16(1):51. DOI: 10.1186/s12920-023-01478-y.
[16] Wu XP, Xu ZQ, Xie WM, et al. Long non-coding RNA GAS6-AS1 enhances breast cancer cell aggressiveness by functioning as a competing endogenous RNA of microRNA-215-5p to enhance SOX9 expression[J]. Exp Ther Med, 2022,23(1):109. DOI: 10.3892/etm.2021.11032.
[17] Zhou H, Liu W, Zhou Y, et al. Therapeutic inhibition of GAS6-AS1/YBX1/MYC axis suppresses cell propagation and disease progression of acute myeloid leukemia[J]. J Exp Clin Cancer Res, 2021,40(1):353. DOI: 10.1186/s13046-021-02145-9.
[18] Cui S, Yang CL, Chen DY. LncRNA EWSAT1 regulates the tumorigenesis of NSCLC as a ceRNA by modulating miR-330-5p/ITGA5 axis[J]. Biochem Genet, 2021,59(6):1441-1456. DOI: 10.1007/s10528-021-10069-4. DOI: 10.1007/s10528-021-10069-4.
[19] Zhu J, Wang L. The role of lncRNA-miR-26a-mRNA network in cancer progression and treatment[J]. Biochem Genet, 2024,62(3):1443-1461. DOI: 10.1007/s10528-023-10475-w.
[20] Safavi P, Moghadam KB, Haghighi Z, et al. Interplay between LncRNA/miRNA and TGF-β Signaling in the tumorigenesis of gynecological cancer[J]. Curr Pharm Des, 2024,30(5):352-361. DOI: 10.2174/0113816128284380240123071409.
[21] Xu S, Lei SL, Liu KJ, et al. circSFMBT1 promotes pancreatic cancer growth and metastasis via targeting miR-330-5p/PAK1 axis[J]. Cancer Gene Ther, 2021,28(3-4):234-249. DOI: 10.1038/s41417-020-00215-2.
[22] Zhao H, Hu GM, Wang WL, et al. LncRNA TDRG1 functions as an oncogene in cervical cancer through sponging miR-330-5p to modulate ELK1 expression[J]. Eur Rev Med Pharmacol Sci, 2019,23(17):7295-7306. DOI: 10.26355/eurrev_201909_18834.
[23] 陈昱颖,张倩,桂梦会,等. PTBP1通过调控FGFR2的可变剪接促进肝癌的发展[J]. 遗传,2024,46(1):46-62. DOI:10.16288/j.yczz.23-224.
[24] Luo A, Lan X, Qiu Q, et al. LncRNA SFTA1P promotes cervical cancer progression by interaction with PTBP1 to facilitate TPM4 mRNA degradation[J]. Cell Death Dis, 2022,13(11):936. DOI: 10.1038/s41419-022-05359-7.
[25] Wang X, Li Y, Fan Y, et al. PTBP1 promotes the growth of breast cancer cells through the PTEN/Akt pathway and autophagy[J]. J Cell Physiol, 2018,233(11):8930-8939. DOI: 10.1002/jcp.26823.
|